Minimally invasive endoscopy in the treatment of preterm premature rupture of membranes by application of fibrin sealant.
We report only the 3rd case of closure of amniorrhexis following genetic amniocentesis. Our technique is the first to use endoscopic visualization of the rupture site and apply maternal platelets and fibrinogen/thrombin (Hemaseel Haemacure Corp Sarasota F1). The patient underwent repair at 20.6 weeks, 26 days after spontaneous rupture of membranes post-amniocentesis. At the time of the procedure the amniotic fluid index was 1 cm. Patient was delivered at 32.3 weeks secondary to complications of diabetes and severe preeclampsia. The neonate had APGARS of 7 at 1 min and 8 at 5 min and was discharged home on Day 21 of life.
Young
B K
BK
New York University School and Medical Center, Department of Obstetrics and Gynecology, USA. byoung530@cs.com
Roqué
H
H
Abdelhak
Y E
YE
Poiolek
D
D
Demopulos
R
R
Lockwood
C J
CJ
D000328:Adult; D000649:Amniocentesis / Q000009:adverse effects; D000653:Amniotic Fluid; D001792:Blood Platelets; D002585:Cesarean Section; D005321:Extraembryonic Membranes / Q000473:pathology; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D005332:Fetoscopy; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage / Q000627:therapeutic use*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007267:Injections; D007751:Labor, Induced; D008297:Male; D010920:Placenta / Q000473:pathology; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D011256:Pregnancy Outcome; D011254:Pregnancy in Diabetics; D016896:Treatment Outcome
D015718:Fibrin Tissue Adhesive